Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Rite Aid Corporation (RADCQ : OTC)

• Company Description    Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager, it provides pharmacy benefits and services nationwide. Its key accomplishments include: i) advancing pharmacy strategy, including rebranding retail stores and Elixir, ii) launching a new member portal at Elixir, iii) expanding business, iv) introducing three flagship remodels and v) expanding COVID-19 testing and vaccinations. The company initiates a strategic plan named RxEvolution, which includes significant rebranding, a merchandising overhaul, new marketing and integration and operational initiatives, in both Retail Pharmacy and Pharmacy Services segments. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $ Daily Weekly Monthly 20 Day Moving Average: shares Shares Outstanding: 55.76 (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $0.23 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL PO Box 3165 - Harrisburg,PA 17105 USA ph: 717-761-2633 fax: 717-975-5871 investor@riteaid.com http://www.riteaid.com

• General Corporate Information    Officers Elizabeth Burr - Chief Executive Officer Bruce G. Bodaken - Chairman Matthew C. Schroeder - Executive Vice President and Chief Financial Offic Steven Bixler - Senior Vice President Bruce G. Bodaken - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: RETAIL-DRUG STR Sector: Retail/Wholesale CUSIP: 767754872 SIC: 5912 Fiscal Year Fiscal Year End: February Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 55.76 Most Recent Split Date: 4.00 (0.05:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: % Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 05/31/25 - - 02/28/25 - - 11/30/24 - - ROA 05/31/25 - - 02/28/25 - - 11/30/24 - - Current Ratio 05/31/25 - - 02/28/25 - - 11/30/24 - - Quick Ratio 05/31/25 - - 02/28/25 - - 11/30/24 - - Operating Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Net Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Pre-Tax Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Book Value 05/31/25 - - 02/28/25 - - 11/30/24 - - Inventory Turnover 05/31/25 - - 02/28/25 - - 11/30/24 - - Debt-to-Equity 05/31/25 - - 02/28/25 - - 11/30/24 - - Debt-to-Capital 05/31/25 - - 02/28/25 - - 11/30/24 - -

Powered by Zacks Investment Research ©